Bio Path reported 0.65 in PE Price to Earnings for its fiscal quarter ending in March of 2025.





Pe Change Date
Baxter International 17.1 4.46 Sep/2025
Cipla 27.74 3.55 Dec/2025
Clal Biotechnology 11.67 2.62 Dec/2022
CSL 16.16 9.59 Dec/2025
Grifols 12.27 4.84 Sep/2025